Cowen and Company’s Aspire Biopharma ASBP Stock Holding History

Cowen and Company’s Portfolio ASBP Stock Details ASBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-98	Closed	-$1.3M	–	726
2024 Q1	$1.3M	Buy	+98	New	+$1.29M	0.05%	145

Other funds holding ASBP

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Cowen and Company's ASBP Position: Q2 2024 in Review

Cowen and Company sold out of Aspire Biopharma (ASBP) in Q2 2024, closing a stake of 98 shares — an estimated $1.3M sold.

Cowen and Company first reported a position in ASBP in Q1 2024 and held it in 1 quarter. The position peaked at $1.3M in Q1 2024. 3 funds tracked by Wall St. Rank hold ASBP as of Q2 2024.

Cowen and Company reported no remaining Aspire Biopharma position as of Q2 2024 after selling out during the quarter.
Cowen and Company sold 98 Aspire Biopharma shares in Q2 2024, an estimated $1.3M.
Cowen and Company first reported a position in Aspire Biopharma in Q1 2024 and held it in 1 quarter.
Cowen and Company's Aspire Biopharma position peaked at $1.3M in Q1 2024.
3 funds tracked by Wall St. Rank held Aspire Biopharma as of Q2 2024.

Based on Cowen and Company's 13F filing for Q2 2024, filed 7 Aug 2024.